PURPOSE:Maximal or peak aerobic capacity (VO(2peak)) during a maximal-effort graded exercise test is considered by many to be the "gold standard" outcome for assessing the effect of exercise training on cardiorespiratory fitness. The reliability of this measure in Parkinson disease (PD) has not been established, where the degree of motor impairment can vary greatly and is influenced by medications. This study examined the reliability of VO(2peak) during a maximal-effort graded exercise test in subjects with PD. METHODS:Seventy healthy middle-aged and older subjects with PD Hoehn and Yahr stage 1.5-3 underwent ascreening/acclimatization maximal-effort treadmill test followed by two additional maximal-effort treadmill tests with repeated measurements of VO(2peak). A third VO(2peak) test was performed in a subset of 21 subjects. RESULTS: The mean VO(2peak) measurement was 2.4% higher in the second test compared with the first test (21.42 ± 4.3 vs 21.93 ± 4.50 mL·kg(-1)·min(-1), mean ± SD, P = 0.03). The intraclass correlation coefficients (ICC) for VO(2peak) expressed either as milliliters per kilogram per minute or as liters per minute were highly reliable, with ICC of 0.90 and 0.94, respectively. The maximum HR (ICC of 0.91) and final speed achieved during the tests (ICC of 0.94) were also highly reliable, with the respiratory quotient being the least reliable of the parameters measured (ICC of 0.65). CONCLUSIONS: Our results demonstrate that measurement of VO(2peak) is reliable and repeatable in subjects with mild to moderate PD, thereby validating use of this parameter for assessing the effects of exercise interventions on cardiorespiratory fitness.
RCT Entities:
PURPOSE: Maximal or peak aerobic capacity (VO(2peak)) during a maximal-effort graded exercise test is considered by many to be the "gold standard" outcome for assessing the effect of exercise training on cardiorespiratory fitness. The reliability of this measure in Parkinson disease (PD) has not been established, where the degree of motor impairment can vary greatly and is influenced by medications. This study examined the reliability of VO(2peak) during a maximal-effort graded exercise test in subjects with PD. METHODS: Seventy healthy middle-aged and older subjects with PD Hoehn and Yahr stage 1.5-3 underwent a screening/acclimatization maximal-effort treadmill test followed by two additional maximal-effort treadmill tests with repeated measurements of VO(2peak). A third VO(2peak) test was performed in a subset of 21 subjects. RESULTS: The mean VO(2peak) measurement was 2.4% higher in the second test compared with the first test (21.42 ± 4.3 vs 21.93 ± 4.50 mL·kg(-1)·min(-1), mean ± SD, P = 0.03). The intraclass correlation coefficients (ICC) for VO(2peak) expressed either as milliliters per kilogram per minute or as liters per minute were highly reliable, with ICC of 0.90 and 0.94, respectively. The maximum HR (ICC of 0.91) and final speed achieved during the tests (ICC of 0.94) were also highly reliable, with the respiratory quotient being the least reliable of the parameters measured (ICC of 0.65). CONCLUSIONS: Our results demonstrate that measurement of VO(2peak) is reliable and repeatable in subjects with mild to moderate PD, thereby validating use of this parameter for assessing the effects of exercise interventions on cardiorespiratory fitness.
Authors: J S Skinner; K M Wilmore; A Jaskolska; A Jaskolski; E W Daw; T Rice; J Gagnon; A S Leon; J H Wilmore; D C Rao; C Bouchard Journal: Med Sci Sports Exerc Date: 1999-11 Impact factor: 5.411
Authors: C Lynne Dobrovolny; Frederick M Ivey; Marc A Rogers; John D Sorkin; Richard F Macko Journal: Arch Phys Med Rehabil Date: 2003-09 Impact factor: 3.966
Authors: Jessica M Scott; Whitney E Hornsby; Amy Lane; Aarti A Kenjale; Neil D Eves; Lee W Jones Journal: Med Sci Sports Exerc Date: 2015-01 Impact factor: 5.411
Authors: Lisa M Shulman; Leslie I Katzel; Frederick M Ivey; John D Sorkin; Knachelle Favors; Karen E Anderson; Barbara A Smith; Stephen G Reich; William J Weiner; Richard F Macko Journal: JAMA Neurol Date: 2013-02 Impact factor: 18.302
Authors: Nicolien M van der Kolk; Sebastiaan Overeem; Nienke M de Vries; Roy P C Kessels; Rogier Donders; Marc Brouwer; Daniela Berg; Bart Post; Bas R Bloem Journal: BMC Neurol Date: 2015-04-16 Impact factor: 2.474
Authors: Foteini Mavrommati; Johnny Collett; Marloes Franssen; Andy Meaney; Claire Sexton; Andrea Dennis-West; Jill F Betts; Hooshang Izadi; Marko Bogdanovic; Martin Tims; Andrew Farmer; Helen Dawes Journal: BMJ Open Date: 2017-12-26 Impact factor: 2.692
Authors: Ali Hakamy; Tricia M McKeever; Michael C Steiner; C Michael Roberts; Sally J Singh; Charlotte E Bolton Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-09-08
Authors: Hélcio Kanegusuku; Tiago Peçanha; Carla Silva-Batista; Roberto Sanches Miyasato; Natan Daniel da Silva Júnior; Marco Túlio de Mello; Maria Elisa Pimentel Piemonte; Carlos Ugrinowitsch; Cláudia Lúcia de Moraes Forjaz Journal: Einstein (Sao Paulo) Date: 2021-04-19